From Golden Rice to Golden Diets : How to turn its recent approval into practice
© 2021 The Authors..
Following its approval in the Philippines in July 2021, provitamin A-rich "Golden Rice" is set to become the worlds' first commercialized genetically modified crop with direct consumer benefits. Despite supplementation and fortification programs, the burden of micronutrient deficiencies remains high. For Golden Rice to be successful in reducing vitamin A deficiency, it needs to be taken up by food systems and integrated into consumer diets. Despite negative information often being associated with genetic engineering, evidence suggests that consumers react positively to Golden Rice. Thus, it offers policy makers and public health stakeholders a new, powerful option to address micronutrient malnutrition that they can integrate as a cost-effective component in broader nutrition strategies and tailor it to consumers' heterogeneous socio-economic contexts and needs to promote "Golden Diets". For this to happen, the right framing of the pathway from policy to consumption is crucial.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Global food security - 32(2022) vom: 31. März, Seite 100596 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
De Steur, Hans [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biofortification |
---|
Anmerkungen: |
Date Revised 17.09.2023 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.gfs.2021.100596 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33830679X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33830679X | ||
003 | DE-627 | ||
005 | 20231226000356.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.gfs.2021.100596 |2 doi | |
028 | 5 | 2 | |a pubmed24n1127.xml |
035 | |a (DE-627)NLM33830679X | ||
035 | |a (NLM)35300044 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a De Steur, Hans |e verfasserin |4 aut | |
245 | 1 | 0 | |a From Golden Rice to Golden Diets |b How to turn its recent approval into practice |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 17.09.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 The Authors. | ||
520 | |a Following its approval in the Philippines in July 2021, provitamin A-rich "Golden Rice" is set to become the worlds' first commercialized genetically modified crop with direct consumer benefits. Despite supplementation and fortification programs, the burden of micronutrient deficiencies remains high. For Golden Rice to be successful in reducing vitamin A deficiency, it needs to be taken up by food systems and integrated into consumer diets. Despite negative information often being associated with genetic engineering, evidence suggests that consumers react positively to Golden Rice. Thus, it offers policy makers and public health stakeholders a new, powerful option to address micronutrient malnutrition that they can integrate as a cost-effective component in broader nutrition strategies and tailor it to consumers' heterogeneous socio-economic contexts and needs to promote "Golden Diets". For this to happen, the right framing of the pathway from policy to consumption is crucial | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biofortification | |
650 | 4 | |a Consumer acceptance | |
650 | 4 | |a Golden rice | |
650 | 4 | |a Planetary health diets | |
650 | 4 | |a The Philippines | |
650 | 4 | |a Vitamin A deficiency | |
700 | 1 | |a Stein, Alexander J |e verfasserin |4 aut | |
700 | 1 | |a Demont, Matty |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Global food security |d 2012 |g 32(2022) vom: 31. März, Seite 100596 |w (DE-627)NLM228598737 |x 2211-9124 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2022 |g day:31 |g month:03 |g pages:100596 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gfs.2021.100596 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 32 |j 2022 |b 31 |c 03 |h 100596 |